"Individual patients and larger health populations alike will benefit as providers share and apply those insights in real-time to drive better, faster and less expensive treatments," IBM stated. "A highly scalable and secure global information platform is essential to pull out individualized insights to help people and providers make timely, evidence-based decisions about health-related issues."
IBM's supercomputer is expected to offer CVS's healthcare providers a more holistic view of each patient, with the ability to coordinate across different provider organizations and detect signs of potential clinical declines in patients.
"CVS pharmacists, nurse practitioners and other health providers will be able to proactively treat the whole patient, when and where they need," IBM stated in a press release.
Watson's predictive analytics capabilities will be aimed at providing information for three main purposes:
Helping to predict individuals at risk for declining health who may benefit from customized engagement programs;
Encouraging patients to adopt safe and healthy behaviors, including adherence to prescribed medicines and healthy lifestyle regimens;
Suggesting appropriate use of cost-effective primary care and out-patient providers.
"This partnership will enable us to leverage advanced technologies and key health information to develop a tool that can be applied by a variety of healthcare providers such as pharmacists, nurse practitioners at MinuteClinics or connected health care providers, and that can help our pharmacy benefit management clients, improve member health and manage cost," Dr. Troyen Brennan, CVS Health's chief medical officer, stated.
Sign up for CIO Asia eNewsletters.